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Abstract
Background: Solid organ transplant recipients show heterogeneity in the occurrence and timing of acute rejection
episodes. Understanding the factors responsible for such variability in patient outcomes may lead to improved diagnostic
and therapeutic approaches. Rejection kinetics of transplanted organs mainly depends on the extent of genetic disparities
between donor and recipient, but a role for environmental factors is emerging. We have recently shown that
major alterations of the microbiota following broad-spectrum antibiotics, or use of germ-free animals, promoted
longer skin graft survival in mice. Here, we tested whether spontaneous differences in microbial colonization
between genetically similar individuals can contribute to variability in graft rejection kinetics.
Results: We compared rejection kinetics of minor mismatched skin grafts in C57BL/6 mice from Jackson Laboratory (Jax)
and Taconic Farms (Tac), genetically similar animals colonized by different commensal microbes. Female Tac mice rejected
skin grafts from vendor-matched males more quickly than Jax mice. We observed prolonged graft survival in Tac mice
when they were exposed to Jax mice microbiome through co-housing or fecal microbiota transplantation (FMT) by gastric
gavage. In contrast, exposure to Tac mice did not change graft rejection kinetics in Jax mice, suggesting a dominant
suppressive effect of Jax microbiota. High-throughput sequencing of 16S rRNA gene amplicons from Jax and Tac mice
fecal samples confirmed a convergence of microbiota composition after cohousing or fecal transfer. Our analysis of
amplicon data associated members of a single bacterial genus, Alistipes, with prolonged graft survival. Consistent with this
finding, members of the genus Alistipes were absent in a separate Tac cohort, in which fecal transfer from Jax mice failed to
prolong graft survival.
Conclusions: These results demonstrate that differences in resident microbiome in healthy individuals may translate into
distinct kinetics of graft rejection, and contribute to interpersonal variability in graft outcomes. The association between
Alistipes and prolonged skin graft survival in mice suggests that members of this genus might affect host physiology,
including at sites distal to the gastrointestinal tract. Overall, these findings allude to a potential therapeutic role for specific
gut microbes to promote graft survival through the administration of probiotics, or FMT.
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Background
Solid organ transplantation is a common treatment for
end-stage organ failure. However, most transplant recipients
need to remain on lifelong immunosuppression to prevent
immune-mediated acute rejection of the donor organ, leav-
ing them susceptible to infections [1], malignancies [2], and
drug toxicity [3]. In the absence of immunosuppression, the
transplant recipient’s immune system recognizes the donor
organ as non-self and mounts an immune response, termed
the alloimmune response [4]. Even in patients taking
immunosuppressive drugs, an alloimmune response can
occur and cause acute graft rejection leading to per-
manent damage to and loss of the transplanted organ.
Importantly, patients who are successfully treated for
episodes of acute rejection experience worse long-term
graft survival than patients who never experience an
acute rejection episode [5].
Recipients of solid organ transplants show heterogeneity
in the occurrence and timing of acute rejection episodes.
While some patients experience acute rejection within the
first year after transplantation, others retain their grafts
long-term despite similar immunosuppression [6, 7], and
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a small subset spontaneously develops operational tolerance,
the ability to maintain allografts without rejection after
withdrawal of immunosuppression [8, 9]. Understanding the
factors responsible for such heterogeneity may lead to im-
proved screening protocols for patients and the develop-
ment of therapeutics to prevent or treat acute rejection.
The likelihood and intensity of acute rejection episodes
is mainly determined by the extent of genetic disparities
between the donor and the recipient of the allograft.
However, a role for environmental factors is emerging.
High-fat [10] and high-salt diet [11] have been shown to
lead to accelerated transplant rejection in mice. Addition-
ally, infection has been associated with increased incidence
of acute rejection in kidney [12, 13] and lung [14, 15]
transplant patients. In mice, infection with Staphylococcus
aureus [16] or Listeria monocytogenes [17] prevented the
induction of graft-specific tolerance and L. monocytogenes
infection could also break transplantation tolerance after it
had been established [18]. Given its role in the develop-
ment and function of the immune system [19], and the
molecular similarity between pathogens and commensal
microbes, the microbiota may also contribute to the inten-
sity of alloimmunity and the kinetics of acute rejection.
Our group has previously shown that germ-free and
antibiotic-pre-treated mice exhibit dampened alloimmu-
nity, and prolonged survival of skin grafts, and that gastric
inoculation of germ-free mice with FMT from conventional
mice is sufficient to accelerate skin graft rejection [20].
These findings indicate that the microbiota is an envir-
onmental factor that can causally affect alloimmunity
and that massive alterations in the microbiota can
translate into measurable differences in graft outcome.
However, the comparison between sterile and colonized
mice is not representative of the differences in micro-
biota composition between individuals. In this study,
using a murine model of skin transplantation, we set
out to determine whether differences in resident micro-
biota between healthy individuals at steady state may
impact graft survival.
Investigating communities of commensal microbes
associated with different skin transplant outcomes may
allow identification of specific members of the microbiota
contributing to transplant rejection. Individual microbial
taxa have been shown to promote varied immune pheno-
types in their hosts. For example, Bacteroides fragilis and
some Clostridium species have been shown to promote
the development of regulatory T cells (TREGS) [21, 22],
and segmented filamentous bacteria have been shown
to promote differentiation of naïve T cells into T helper
17 (TH17) cells [23] in the gut mucosa. With the recent
discovery of specific microbes modulating anti-tumor
immunity [24–26], susceptibility to rheumatoid arthritis
[27, 28], experimental autoimmune encephalomyelitis
[22], and other immune-mediated diseases distal to the
gut in mouse models [29], we sought to identify members
of the gut microbiota associated with improved or worsened
transplant survival. Here, we provide evidence that members
of the genus Alistipes are associated with improved survival
of transplanted skin in mice.
Results
Microbiota composition differs in Jax and Tac mice of the
same genetic background
To determine whether specific commensal microbes could
impact skin transplantation outcomes, we obtained mice of
the same C57BL/6 (B6) genetic background from different
vendors as they have been shown to be colonized by differ-
ent communities of commensal microbes [23, 24]. We
performed 16S rRNA gene amplicon sequencing of fecal
samples from Jax and Tac mice upon their arrival to our
facility. We inferred highly resolved microbial community
structures in our amplicon data with Minimum Entropy
Decomposition (MED). MED iteratively decomposes a
given amplicon dataset using highly variable nucleotide
positions identified by Shannon entropy, until the variation
within the population of amplicon sequences that resolve to
the same oligotype, or “amplicon sequence variant” (ASV),
is minimal [30]. This strategy allows the identification
of closely related but distinct taxa at a single-nucleotide
resolution, better explaining micro-diversity compared
to clustering strategies that rely on arbitrary similarity
thresholds [31–34].
MED identified 195 ASVs present in female Jax or Tac
mice (Additional file 1). Female Jax and Tac mice were
both colonized almost entirely by members of the phyla
Firmicutes and Bacteroidetes and a small proportion of
the phylum Tenericutes (Fig. 1a left, Additional file 2),
which agrees with previous studies [24]. Tac mice were
also colonized by a small proportion of ASVs assigned to
the phylum Verrucomicrobia. While these ASVs made
up only 2.1% of the Tac mice microbiota on average, this
was a relative abundance 700-fold greater than in Jax
mice. This lack of Verrucomicrobia members in Jax mice
is consistent with our previous findings [24].
To gain an understanding of the differences between
Jax and Tac microbiota composition beyond taxonomic
annotations, we compared the most abundant ASVs in
Jax and Tac mice that made up at least 50% of the overall
composition of each mouse (Fig. 1a right, Additional file 3).
The distribution of the 12 ASVs that matched this criterion
differed remarkably between Jax and Tac mice except two.
One of the two ASVs that were similarly abundant in both
groups (ASV_10871) could not be assigned taxonomy
beyond the order Bacteroidales, while the other (ASV_66)
resolved to the genus Lactobacillus. Five of the remaining
ten ASVs (8132, 10739, 12136, 12072 and 12134) were
specific to Tac mice, as they were detected in every Tac
mouse while being virtually undetected in Jax mice. None
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of the Tac-specific ASVs could be assigned taxonomy at a
level higher than Bacteroidales order. Remaining five
ASVs were specific to Jax mice, three of which (ASVs
1857, 1858, and 4421) were not assigned beyond the
order Bacteroidales, and the last two were assigned to
Allobaculum (ASV_100) and Alistipes (ASV_5969).
Some lower abundance ASVs were also differentially
abundant between Jax and Tac mice (Additional file 3).
Relative abundance of ASVs_122, 5039, and 5968 were
all over 1000-fold higher in Tac than in Jax mice and were
assigned to family Prevotellaceae, genus Lactobacillus, and
genus Parabacteroides, respectively. Conversely, the
Bacteroidales-assigned ASV_1859 was over 1000-fold
more abundant in Jax than in Tac.
a
b
d
c
Fig. 1 Cohousing with Jax B6 mice results in prolonged skin transplant survival in Tac B6 mice. a Representation of phyla (left) or the 12 ASVs with highest
average percent relative abundance across pre-cohousing Jax and Tac samples (right) after 16S rRNA gene sequencing and clustering of amplicons into
ASVs using MED in female Tac and Jax B6 mice. Each column represents an individual mouse. All phyla contributing to at least 1% of overall microbial
composition are labeled and shown in color. b–d Survival of vendor-matched male B6 skin transplants in female Tac and Jax B6 mice housed separately or
following cohousing of Jax and Tac skin graft donors and cohousing of Jax and Tac recipients for 3 weeks prior to transplantation. *P< 0.05, ****P< 0.0001;
ns = not significant
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Skin graft rejection kinetics in Tac mice are affected by
cohousing or FMT
Following our observation of differences in microbiota
composition between Jax and Tac mice arriving at our
facility, we compared the kinetics of rejection of skin grafts
bearing sex-dependent minor (non-major histocompatibility
complex) mismatches, as skin from male mice expresses
H-Y antigens encoded by the Y chromosome [35, 36]. H-Y
antigens are recognized following transplantation by the
immune system of otherwise genetically identical female
recipients, resulting in rejection. We grafted skin from male
B6 Jax and Tac mice to their female B6 counterparts from
the same vendor (Fig. 1b) and monitored animals to
determine the length of time until each graft was rejected
(Fig. 1d). Female Tac mice rejected male skin grafts signifi-
cantly faster (MST 18 ± 3 days, n = 10) than did female Jax
mice (MST 24 ± 2 days, n = 8; P < 0.001). To eliminate the
possibility that genetic drift in B6 mice at Jax or Tac facilities
had contributed to the observed differences in rejection
kinetics, we cohoused Jax and Tac skin graft donor mice
together for 3 weeks prior to transplantation, and Jax and
Tac skin graft recipients together for 3 weeks prior to trans-
plantation (Fig. 1c), to allow transfer of some environmental
factors, including commensal microbes, between individuals
from different vendors, while preserving any existing host
genetic differences. In support of an environmental but not
host genetic cause for the delayed rejection in Jax mice,
Tac mice rejected grafts with slower Jax-like kinetics
after cohousing (Fig. 1d) (MST 21 ± 4 days, n = 7; P = 0.02
when compared to Tac mice housed separately from Jax
mice). In contrast, rejection kinetics in Jax mice remained
unchanged (MST 24 ± 3 days, n = 7) when compared with
Jax mice housed separately from Tac mice, suggesting that
Jax mice were transferring a dominant inhibitory factor to
Tac mice by cohousing, rather than Jax mice losing a
graft-protective factor or gaining a rejection-accelerating
factor by cohousing with Tac mice.
Because components of the fecal microbiota are trans-
ferred between cohoused mice, we sought to determine
whether the environmental factor responsible for differ-
ences in skin transplantation outcomes in Jax mice could
be found in Jax feces. To this end, skin graft donor and
skin graft recipient Tac mice received gastric FMT from
Jax mice, prior to skin transplantation (Fig. 2a). Indeed,
Jax FMT into Tac mice promoted slower skin graft
rejection by Tac mice when compared to Tac skin graft
recipients that had received Tac FMT (MST 21 ± 1 days,
n = 5 versus 15 ± 3 days, n = 4; P < 0.005) (Fig 2b). In
contrast, Tac or Jax FMT into Jax mice did not change
graft rejection kinetics in Jax mice (MST 20 ± 4 days,
n = 4 versus MST 22 ± 2 days, n = 3). This confirmed the
presence of a component of Jax feces that dominantly
prolonged skin graft survival and could be transferred to
Tac mice by FMT.
Jax FMT to both Tac skin graft donor and Tac skin graft
recipient is required for maximal prolongation of graft
survival
In organ transplantation, genetic or environmental factors
associated with either the donor or the recipient could
influence the rejection of the transplanted organ. For
instance, polymorphisms of both the transplant donor
[37, 38] and recipient [39–41] have been shown to impact
graft rejection, and we have previously demonstrated that
antibiotic pre-treatment needs to be administered to both
the donor and the recipient to result in prolonged skin
graft survival [20]. In the cohousing and fecal transfer
experiments described in Figs. 1 and 2, skin donors and
recipients were both cohoused or given FMT prior to
transplantation, so the effect of Jax feces on graft survival
could have occurred through changes to the donor and/or
recipient. To determine whether the improvement in skin
transplantation outcome in Tac mice after exposure to Jax
microbiota occurred through changes to the donor, recipi-
ent, or both, only Tac skin graft donors or recipients
received FMT from Jax mice prior to transplantation
(Fig. 2c). While Jax FMT into only the Tac skin graft
donor (MST 19 ± 1 days, n = 5) or only the Tac skin
graft recipient (MST 19 ± 1 days, n = 4) led to a slight
improvement in skin transplant survival compared to
Tac FMT into Tac mice (MST 16 ± 2 days, n = 5), Jax
FMT into both Tac skin graft donor and recipient led
to more significant prolongation in graft survival (MST
23 ± 3 days, n = 5; P < 0.01) when compared to Tac
FMT. Thus, maximal skin graft survival improvement
by Jax FMT required that both the Tac skin graft donor
and the Tac skin graft recipient receive the Jax FMT.
Convergence of fecal microbiota composition in Jax and
Tac mice following cohousing and FMT
To determine whether Jax fecal transfer led to changes
in the microbiota of Tac mice, we compared microbial
community profiles in samples from Jax and Tac mice
before and after cohousing or FMT experiments. The
distinct composition of Jax and Tac microbiota compos-
ition at baseline and their convergence after cohousing or
cross-vendor FMT was clearly evident in the relative
abundance of microbes at the ASV level (Figs. 3a and 4a).
Principal coordinate analysis (PCoA) of these data also
revealed a clear separation of Jax (n = 7) and Tac (n = 6)
fecal samples at baseline and a convergence of Jax (n = 7)
and Tac (n = 7) microbiota composition following
cohousing (Fig. 3b). PCoA showed a separation between
Jax and Tac mice following FMT from vendor-matched
fecal donors, but similar to cohousing, cross-vendor-FMT
resulted in a convergence of microbiota composition
(Fig. 4b). Alpha diversity as defined by Shannon entropy
or inverse Simpson index was similar in Jax and Tac fecal
samples, and longer graft survival did not correlate with
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differences in alpha diversity (Additional file 4). These
results suggest that one or more taxa are transferred from
Jax to Tac by cohousing or FMT and that the transfer is
associated with prolonged skin graft survival in Tac mice.
We then analyzed the microbial community structure
between these cohorts to determine which taxa changed in
Tac mice following cohousing with Jax mice or following
Jax FMT that could explain the improvement in rejection
kinetics in Tac mice. To gain a broad view of the efficiency
of microbial transfer in our experiments, we determined
the number of ASVs detected in the majority of mice from
either Jax or Tac prior to cohousing or FMTand quantified
how many of these ASVs were gained or lost post cohous-
ing or FMT (Additional file 5). Of 30 Jax-specific ASVs, 14
were gained by Tac mice post cohousing and 21 out of 27
Tac-specific ASVs were gained by Jax post cohousing.
Fourteen of 60 Jax-specific ASVs were transferred to
Tac by Jax FMT, and 8 of 15 Tac-specific ASVs were
transferred to Jax by Tac FMT. Five ASVs were gained
by Tac mice by both cohousing and Jax FMT. Three
ASVs were gained by Jax mice by both cohousing and
Tac FMT.
We chose to focus further analysis on ASVs that had a
relative abundance of at least 1% in a minimum of two
mice from either Jax or Tac at baseline, reasoning that
very low abundance microbes were more likely to represent
sequencing errors. Of the 34 ASVs meeting our criteria for
inclusion, our analysis revealed 24 ASVs that were differen-
tially abundant between Jax and Tac mice upon arrival at
our facility (Additional file 6). Following cohousing, none
of those 24 ASVs remained significantly different between
Jax and Tac, and the relative abundance of only five (ASVs_
b
a
c
Fig. 2 Jax FMT into both Tac skin transplant donor and recipient mice delays skin transplant rejection. a Treatment schedule for mice receiving
Jax or Tac FMT. b Survival kinetics of vendor-matched male B6 skin transplants in female Jax or Tac B6 graft recipients following Jax or Tac FMT
into both skin transplant donor and recipient. c Survival of male Tac B6 skin transplants in female Tac B6 recipients following Jax or Tac FMT into
skin transplant donor and/or recipient. *P < 0.05, **P < 0.01; ns = not significant
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3100, 5969, 8132, 12134, and 12135) had changed in Tac
mice before and after cohousing with Jax (Fig. 3c, d).
ASVs_100 and ASV_5969 were present only in Jax mice at
baseline and were transferred to Tac mice by cohousing,
while remaining unchanged in Jax mice. Three ASVs that
resolved to the Bacteroidales order (ASVs_8132, 12134,
and 12136) were present only in Tac mice at baseline, and
their abundance increased significantly in Jax mice after
cohousing. They also decreased two to threefold in relative
abundance in Tac mice after cohousing, though the increase
in these ASVs in Jax mice was far greater than their decrease
in Tac mice. Because ASVs_100 and ASV_5969 only
changed in Tac following cohousing, we reasoned that
the abundance of these ASVs tracked best with delayed
skin transplant rejection and that these were the best
candidates for ASVs promoting skin transplant survival.
Next, we analyzed taxonomic composition of the fecal
microbiota in Jax and Tac mice prior to and following
a
b
d
c
Fig. 3 Jax and Tac microbiota composition converges following cohousing. a Heat map of percent relative abundance of ASVs in Jax and Tac
mice before and after cohousing. Each row represents an individual mouse. Each column represents a single ASV. Only ASVs with percent relative
abundance of at least 1% in a minimum of two samples from the same vendor before cohousing were included. Arrangement of ASVs was kept
constant between all rows. Bottom row displays the phylum to which the ASV in the same column was assigned. b Principal coordinate analysis
of female B6 Jax and Tac fecal microbiota composition using Bray-Curtis distance prior to or following cohousing of Jax and Tac mice for 3 weeks. Each dot
represents an individual mouse. c, d Percent relative abundance of all ASVs significantly differentially abundant between Tac and Jax before cohousing and
between Tac before and after cohousing with Jax, but not significantly different between Jax and Tac after cohousing. Each dot represents an individual
mouse. *P< 0.05, ns = not significant
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Jax or Tac FMT (Additional file 7). ASVs_100 and ASV_
5969 were again detected in Jax (n = 5) but not Tac (n = 4)
mice upon arrival at our facility (Fig. 4c). Following Jax
FMT into Tac (n = 5), relative abundance of ASV_100 rose
in two mice to match relative abundance in Jax mice but
returned to nearly undetectable levels within 15 days after
FMT. Tac mice gavaged with Tac feces (n = 4) also acquired
some ASV_100. Jax mice maintained relatively high levels
of ASV_100 whether gavaged with Jax or Tac feces, though
the relative abundance did drop in some Jax mice. Much
better correlated with graft outcome was ASV_5969, which
was consistently transferred to Tac mice given Jax FMT,
reaching levels similar to those seen in Jax mice. Relative
abundance of ASV_5969 remained consistently high 15 days
following the last FMT, showing that colonization was
stable over time and through the stress of surgery. Jax mice
maintained consistently high levels of ASV_5969 whether
given FMT from Jax (n = 5) or Tac (n = 4) mice. We also
note that, slower or faster skin graft rejection was associated
with the presence or absence of ASV_100 and ASV_5969,
independent of their relative abundance in animals in which
they were detected (data not shown).
ASV_100 and ASV_5969 were absent from an outlier
cohort where Jax FMT did not prolong skin transplant
survival in Tac mice
Importantly, in one experiment, Tac mice treated with
Jax FMT did not display delayed rejection kinetics (MST
19 ± 2 days, n = 5) when compared with Tac FMT-treated
Tac mice (MST 19 ± 1 days, n = 5) (Fig. 5a), affording us the
opportunity to compare microbiota composition between
these Jax FMT-treated Tac mice with fast rejection kinetics
(fast Jax to Tac) and Jax FMT-treated Tac mice with delayed
graft rejection from prior experiments (slow Jax to Tac). We
performed a PCoA of 16S rRNA gene sequencing data in
fecal DNA isolates from Tac FMT-treated Tac mice (Tac to
Tac 1, n = 3 and Tac to Tac 2, n = 4), slow Jax FMT-gavaged
Tac mice (n = 5), and fast Jax FMT-gavaged Tac mice
(n = 3) using Bray-Curtis distance. Our analysis revealed
that mice exhibiting delayed skin graft rejection (slow Jax
FMT-gavaged Tac mice) clustered separately from mice
rejecting grafts more quickly (Tac mice and fast-Jax FMT-
treated Tac mice) (Fig. 5b), supporting our hypothesis that
microbiota composition impacts graft rejection kinetics.
Consistent with a role for ASV_100 or ASV_5969 in
a b
c
Fig. 4 Jax and Tac microbiota composition converges following FMT, including transfer of ASVs transferred by cohousing. a Heat map of percent
relative abundance of ASVs in Jax and Tac mice before FMT, or 1 day after the third FMT from either vendor-matched fecal donor (self-FMT) or
fecal donor from different vendor (cross-FMT). Each row represents an individual mouse. Each column represents a single ASV. Only ASVs with
percent relative abundance of at least 1% in a minimum of two samples from the same vendor were included. Arrangement of ASVs was kept
constant between all rows. Bottom row displays the phylum to which the ASV in the same column was assigned. b Principal coordinate analysis
of female B6 Jax and Tac fecal microbiota composition using Bray-Curtis distance following either self-FMT (Jax to Jax, Tac to Tac) or cross-FMT
(Tac to Jax, Jax to Tac). c Percent relative abundance of ASVs associated with prolonged graft survival in Jax and Tac mice either pre-FMT, or 1 or
15 days after the third self-FMT or cross-FMT. Each dot represents an individual mouse. *P < 0.05, ns = not significant
McIntosh et al. Microbiome  (2018) 6:96 Page 7 of 12
prolonging skin graft survival, fast Jax FMT-treated Tac
mice were nearly devoid of both of these ASVs (n = 2,
Fig. 5c, Additional file 8).
Discussion
In this study, we have determined that the composition
of the fecal microbiota impacts the kinetics of skin
transplant rejection in otherwise unmanipulated mice (i.e.,
not treated with antibiotics nor immunosuppressed). In
the human population, there is a large diversity of micro-
biota composition between individuals, variability which
can already be observed within the first year of life [42].
Even within an individual, large shifts in microbiota com-
position can occur through time following dietary changes
[42, 43]. Our findings show that such differences in micro-
bial community composition between individuals at steady
state, independent of genetic differences between graft
donor and recipient, can translate into varied kinetics
of graft rejection and may therefore contribute to inter-
patient variability in transplant outcomes.
We have identified a specific bacterial group that resolved
to the genus Alistipes (ASV_5969), whose presence consist-
ently correlated with delayed skin graft rejection in Jax mice
or in Tac mice following cohousing with Jax mice or follow-
ing Jax FMT pre-treatment. While transfer of ASV_5969
from Jax to Tac was consistently associated with prolonged
graft survival, the mechanism by which members of this
ASV could provide such an effect remains uncertain. Pro-
longation of skin graft survival could occur through directly
or indirectly dampened adaptive alloimmunity, improved
wound healing, or other processes impacting longevity of a
transplanted organ. Alternatively, ASV_5969 may be dis-
placing, after transfer into Tac mice, microbial species that
promote faster graft rejection. Such displacement would
need to be broadly distributed across different genera and/
or variable between individuals as we did not detect
any microbial taxon consistently displaying a negative
correlation with skin transplant survival. Members of
ASV_5969 may also inhibit certain behaviors of other
commensal microbes that promote graft rejection without
limiting their colonization.
Interestingly, optimal prolongation of skin transplant
survival in Tac mice required treating both the skin
transplant donor and the skin transplant recipient with
Jax FMT. As the female skin transplant recipient only
receives skin from the male skin transplant donor, and
the graft is disinfected with ethanol prior to transplant-
ation, this finding suggests that the effect of Jax FMT in
the transplant donor is localized to the skin tissue itself.
The skin tissue may be affected, before its harvest for
a b
c
Fig. 5 Skin transplant survival-associated ASVs are missing from cohort of Jax to Tac mice with fast rejection. a Male B6 Tac skin transplant survival
kinetics in an outlier cohort of female B6 Tac mice that had received Jax or Tac FMT. b Principal coordinate analysis of microbiota composition
using Bray-Curtis distance in female Tac B6 mice treated with Tac FMT (Tac to Tac 1 and Tac to Tac 2), with Jax FMT that delayed graft rejection
(Slow Jax to Tac) or Jax FMT that did not delay graft rejection (Fast Jax to Tac). Each dot represents an individual mouse. c Percent relative abundance
of ASVs previously associated with prolonged graft survival (ASV_100 and ASV_5969) in Tac mice shown in a 1 day after the third Tac or Fast Jax FMT.
ns = not significant
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transplantation, by soluble factors circulating from the
intestine to the skin, or by direct contact with the modi-
fied feces in the cage. Alternatively, we cannot eliminate
the possibility that some Jax-derived microbes resist skin
disinfection and modulate the immune system of the
skin graft host after transplantation. Nevertheless, despite
differences in microbiota between male and female mice
evident in our data as well as in previous reports [44],
ASV_5969 was transferred from Jax to Tac in both
male skin graft donors and female skin graft recipients
(Additional files 9 and 10), supporting the hypothesis
that the same immune modulation is at play in the
graft donor and graft recipient.
While mechanisms behind these observations warrant
further study, our data suggest a potential immunomodula-
tory role for the Alistipes population identified by ASV_
5969. Not much is known about the immune impact of
individual members of the Alistipes genus. One species,
Alistipes shahii, has been associated with increased, rather
than diminished, immune responses, as it has been shown
to improve efficacy of anti-tumor immunotherapy in a
mouse model [26]. This effect was attributed to lipopolysac-
charide (LPS) on the surface of A. shahii acting as a TLR4
ligand, promoting tumor necrosis factor production
and thus enhanced anti-tumor immunity. It is unlikely
that Alistipes is promoting graft survival through LPS-
TLR4 interactions, as it is polymorphisms associated
with loss rather than gain of function in TLR4 that have
been shown to be protective from acute rejection in
humans [45, 46], and signaling through TLR4 has been
shown to promote rejection in a mouse skin graft
model [47].
An alloimmunity-dampening mechanism more consistent
with our findings relates to the recent report that Alistipes
members produce the anti-inflammatory metabolite
sulfobacin B [48]. In vitro, incubation of macrophages
with sulfobacin B has been shown to inhibit production
of tumor necrosis factor (TNF) and nuclear translocation
of nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-κB) following stimulation with lipopolysaccharide
(LPS) [49]. In vivo, intraperitoneal injection with sulfobacin
A lessened the inflammatory response to phorbol 12-
myristate 13-acetate and LPS. In our Alistipes-colonized
transplant recipients, it is conceivable that sulfobacin B
might similarly impair NF-κB signaling and TNF pro-
duction, leading to a reduction in the strength of the
alloimmune response and thus delayed allograft rejection.
Consistent with this, in preliminary results, we found
reduced expression of TNF transcripts in the lymph
nodes of skin transplanted Jax mice when compared to
Tac mice.
While graft survival was only prolonged by several
days in our slow-rejecting experimental groups, this modest
survival increase may be biologically relevant. Indeed, we
and our collaborators previously found similar differences
in kinetics of tumor growth in mice obtained from different
vendors and differences in tumor control were significantly
amplified when the animals were treated with anti-PDL1, a
checkpoint blockade therapy [24]. We have since extended
these data to the clinical setting and confirmed that differ-
ences in the fecal microbiota observed prior to initiation of
checkpoint blockade therapy could predict responsiveness
to subsequent immunotherapy in melanoma patients [50].
These findings as well as a recent study showing synergy of
low-dose tacrolimus with FMT from mice treated with
high-dose tacrolimus in delaying the rejection of major
mismatched skin allografts in mice [51] suggest that
small effects of the microbiota at steady state on tumor
control or graft survival may be amplified by pharmacologic
treatments. While our study has utilized a minor mismatch
model of skin transplant rejection to provide a better
window to observe either acceleration or delay in rejection
kinetics without requiring immunosuppression, we have
recently shown that antibiotic pre-treatment of skin
graft donors and recipients can prolong survival of major
mismatched skin grafts as well, supporting a wider role of
the microbiota in various transplantation settings [20].
The shift in graft rejection kinetics observed between
Tac mice treated with slow Jax-FMT and Tac mice
treated with fast Jax-FMT, despite the Jax fecal donors
originating from the same room in the same breeding fa-
cility at Jackson Laboratories, should provide a cautionary
tale to investigators, as changes in microbial community
composition that may occur over periods of time can
impact the phenotype of interest.
One of the most noteworthy outcomes of our study is
that there may be microbial populations that consistently
colonize newly exposed mice and prolong graft survival.
This observation suggests that whether patients undergoing
organ transplantation may benefit from probiotic therapies
or FMT warrants further research.
Our results also highlight the importance of under-
standing the effects of surgery and medications given to
transplant recipients on microbiota composition, and the
potential for them to induce colonization by microbes
promoting or impairing graft survival. Studies have shown
changes to the microbiota of liver transplant recipients
following transplantation, though no changes to relative
abundance of Alistipes were observed [52]. While the
cause of microbiota changes in transplant recipients
remains unknown, a recent study has shown that between
multiple immunosuppressive drugs commonly used in
transplantation, only steroids significantly impacted the
composition of the mouse fecal microbiota, including a
reduction in Bacteroidetes and an increase in Firmicutes
[53]. Whether these post-transplantation changes to the
microbiota have a meaningful impact on transplant
outcomes remains to be investigated.
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Conclusions
Our comparison of skin transplant rejection kinetics in
mice of the same genetic background from different
commercial vendors demonstrated that the composition
of the resident microbiome in healthy individuals can
impact the kinetics of transplant rejection, and may thus
also contribute to inter-individual variability in graft out-
comes in patients. We identified a single ASV that was
consistently and stably transferred from the fecal micro-
biota of Jax to Tac and which was associated with pro-
longed skin graft survival in Tac mice. These observations
suggest that we need to better understand transplant-
ation-associated changes to patient microbiota compos-
ition as these changes may impact transplant outcomes.
Methods
Mice
We obtained C57BL/6 (B6) from Jackson Laboratory
or Taconic Farms and performed all experiments using
6–8-week-old male or female mice. We fed mice with
Harlan Teklad 2018 diet, maintained them on distilled
water, and housed them in individually ventilated cages in
a specific pathogen-free animal facility at the University
of Chicago. We collected fecal samples directly into
autoclaved tubes, avoiding contact with mouse skin or
urine, and stored them at − 20 °C until DNA isolation.
Skin transplantation
We transplanted tail skin from male B6 mice onto the flank
of female B6 recipients as previously described [54] and re-
moved bandages after 7 days, while monitoring the graft
survival every other day thereafter. We reported “rejection”
when less than 20% of transplanted skin was viable.
Cohousing and FMT experiments
For cohousing experiments, we kept two or three B6
mice from each Jax and Tac cohort in the same cage
(five mice/cage) for 3 weeks prior to transplantation.
Cohousing experiments prior to transplantation included
both skin transplant donors and recipients grouped
based on their gender. For FMT experiments, male mice
received oral FMT from male mice, while female mice
received oral FMT from female mice. FMT donor mice
arrived from Jax or Tac in the same shipments as FMT
recipient mice, but were housed separately from FMT
recipients. We prepared a separate fecal suspension from
each of three FMT donor mice by suspending one fecal
pellet in 1 mL sterile phosphate buffered saline using a
syringe and 18-gauge needle (Becton Dickinson) until all
volume could pass through the needle. We allowed partic-
ulates to settle for 30 s before drawing supernatant into a
syringe attached to a 22-gauge gavage needle (Fine Science
Tools). We pooled together 500 μL of the supernatants
from each of the three 1 mL suspensions and deposited
200 μL of this pooled supernatant into the stomach of
each recipient mouse by gavage. Each FMT recipient was
gavaged 7, 4, and 1 days prior to skin transplantation, with
donor feces freshly harvested from the same three Jax or
Tac FMT donors immediately prior to gavage, and the first
FMT obtained upon arrival of the Jax or Tac mice to
our facility. We cleaned gavage needles with 70% ethanol
between mice, using different gavage needles for each
treatment group. We cleaned gavage needles with 70%
ethanol and autoclaved them after the final gavage on each
experimental day.
Microbial DNA isolation, sequencing library preparation,
and analysis
QIAamp DNA Stool Mini Kit (QIAGEN) extracted the
DNA from fecal samples homogenized with 0.1 mm
zirconia/silica beads in 1.4 mL ASL buffer (QIAGEN)
in a Mini-Beadbeater (Biospec). The Environmental
Sample Preparation and Sequencing Facility at Argonne
National Laboratory (Argonne, IL, USA) performed library
preparation and sequencing of our DNA isolates. Thirty-
five cycles of amplification were performed using primers
[55] that target the V4-V5 region of the 16S rRNA gene to
generate our amplicons from purified DNA, and Illumina
MiSeq paired-end sequencing (2 × 300) was used to
sequence our amplicon libraries at the High-Throughput
Genome Analysis Core in the Argonne National Laboratory.
Quantitative Insights Into Microbial Ecology (QIIME) soft-
ware [56] joined paired-end sequences and de-multiplexed
raw sequencing data into samples. We identified ASVs in
our dataset to infer high-resolution microbial community
structures using Minimum Entropy Decomposition [30]
(MED) via the previously described oligotyping pipeline
[57]. We used Global Alignment for Sequence Taxonomy
(GAST) [58] to infer the taxonomic affiliation of each
ASV. After identifying ASVs, QIIME calculated alpha
diversity estimates with Shannon entropy and inverse
Simpson index. We performed principal coordinate ana-
lysis (PCoA) to infer similarities between samples based
on their microbial community structures using the relative
abundances of ASVs and the Bray-Curtis distance with the
R package phyloseq [59] after removing samples with less
than 2500 reads. We generated heat map visualizations of
ASV percent relative abundances using anvi’o v3 [60].
Statistical analysis
Kaplan-Meier plots and log-rank (Mantel-Cox) tests com-
pared graft survival curves, and unpaired Mann-Whitney
tests with Sidak-Bonferroni correction compared the relative
abundance of microbial taxa across samples. We used Prism
6 (Graphpad) for statistical analyses and considered P < 0.05
to be statistically significant denoting levels of significance
with increasing numbers of asterisks in our text and figures:
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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Additional file 1: ASV counts and number of ASVs detected in all
samples. Tables providing total read counts, read counts for each ASV
with assigned taxonomy, and the number of ASVs detected for each
sample. (XLSX 119 kb)
Additional file 2: Phylum-level fecal microbiota composition in Jax and
Tac mice at baseline. Table providing percent relative abundance of all
detected phyla in Jax and Tac fecal samples at baseline. (XLSX 10 kb)
Additional file 3: Fecal microbiota ASVs in Jax and Tac mice at baseline.
Table providing percent relative abundance of all ASVs and their
assigned taxonomy in Jax and Tac fecal samples at baseline and the 12
most abundant ASVs when averaged across all samples. Some ASVs listed
were not detected in these samples but were detected in other samples
from this study. (XLSX 52 kb)
Additional file 4: Alpha diversity of the fecal microbiota is not
associated with prolonged skin transplant survival in Jax mice. Figure showing
Shannon entropy and inverse Simpson index of fecal microbiota from female
Jax and Tac skin transplant recipients A. before and after cohousing, and B.
before and after FMT from male Jax or Tac mice. (PDF 788 kb)
Additional file 5: Transfer efficiency of ASVs following cohousing or
FMT. Tables identifying ASVs detected in the majority of mice from either
Jax or Tac prior to cohousing or FMT and which of these ASVs were
gained or lost by cohousing or FMT. (XLSX 233 kb)
Additional file 6: Fecal microbiota ASVs in Jax and Tac mice before and
after cohousing. Tables providing percent relative abundance of all ASVs
and their assigned taxonomy in Jax and Tac fecal samples before and
after cohousing with results of statistical analysis. Some ASVs listed were
not detected in these samples but were detected in other samples from
this study. (XLSX 100 kb)
Additional file 7: Fecal microbiota ASVs in Jax and Tac mice before and
after FMT. Tables providing percent relative abundance of all ASVs and
their assigned taxonomy in Jax and Tac fecal samples before FMT and
after self-FMT or cross-vendor-FMT with results of statistical analysis. Some
ASVs listed were not detected in these samples but were detected in
other samples from this study. (XLSX 79 kb)
Additional file 8: Fecal microbiota ASVs in outlier Tac cohort where Jax
FMT did not improve graft survival. Table providing percent relative
abundance of all ASVs and their assigned taxonomy and results of
statistical analysis in Tac mice following Jax or Tac FMT in a cohort where
Jax FMT did not prolong graft survival. Some ASVs listed were not
detected in these samples but were detected in other samples from this
study. (XLSX 27 kb)
Additional file 9: Fecal microbiota ASVs in male skin transplant donors.
Table providing percent relative abundance of all ASVs and their
assigned taxonomy in all male skin transplant donors used in this study.
Some ASVs listed were not detected in these samples but were detected
in other samples from this study. (XLSX 33 kb)
Additional file 10: Relative abundance of ASV_5969 in skin transplant
donors is associated with prolonged skin transplant survival. Figure
showing percent relative abundance of transplant survival-associated
ASVs in male Jax and Tac skin transplant donors A. before and after
cohousing, B. before and after FMT from male Jax or Tac mice, and C.
after FMT from male Tac or Fast Jax mice. (PDF 764 kb)
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